-
公开(公告)号:US20220395521A1
公开(公告)日:2022-12-15
申请号:US17579067
申请日:2022-01-19
Applicant: Kaleido Biosciences, Inc.
Inventor: Geoffrey A. von Maltzahn , John M. Geremia
IPC: A61K31/7004 , A61K45/06 , A61K31/19 , A61K31/197 , A61K31/198 , A61K31/192 , A61K31/733 , A61K31/702 , A61K31/716 , A61K9/00 , A61K31/047 , A61K31/7016 , A61K35/741 , C12Q1/10
Abstract: Compositions comprising microbiome regulators are provided, as well as methods of using the same for the modulation of the human microbiota and to treat or prevent related diseases, disorders, or conditions.
-
公开(公告)号:US20210161942A1
公开(公告)日:2021-06-03
申请号:US16630116
申请日:2018-07-13
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor: Geoffrey A. von Maltzahn , Jacob Rosenblum Rubens
IPC: A61K31/715 , A61K45/06
Abstract: Compositions, e.g., pharmaceutical compositions, nutritional compositions, medical foods, and food ingredients, as well as their methods of use, are provided, for modulating exogenous substances, enzyme activities, and drug activities.
-
公开(公告)号:US20210113596A1
公开(公告)日:2021-04-22
申请号:US16883107
申请日:2020-05-26
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor: Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
IPC: A61K31/702 , A61K45/06 , A61K31/716 , A61K31/733 , A61P1/00 , A61K31/09 , A61K31/11 , A61K31/12 , A61K31/165 , A61K31/34 , A61K31/353 , A61K31/365 , A61K31/366 , A61K31/7034 , A61K31/7048 , A61K31/706 , A61K31/715 , A23L33/10 , A23P10/00 , A61K31/7004 , A61K31/7016 , A61K35/741
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
-
公开(公告)号:US20190290675A1
公开(公告)日:2019-09-26
申请号:US16466945
申请日:2017-12-06
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor: Molly Krisann Gibson , Christopher Matthew Liu , Geoffrey A. von Maltzahn , Han Yuan
IPC: A61K31/716 , A61K9/00 , A61P3/00
Abstract: Compositions of glycan polymers and methods of making and manufacturing the same are described herein. Also provided are methods of treating a disease or disorder with a glycan polymer preparation.
-
公开(公告)号:US10314853B2
公开(公告)日:2019-06-11
申请号:US15624372
申请日:2017-06-15
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor: Geoffrey A. von Maltzahn , Jared Silverman , Yvonne J. Yamanaka , John Miles Milwid , John M. Geremia
IPC: A61K31/702 , A61K31/716 , A23P10/00 , A61K45/06 , A61K35/741 , A23L33/10 , A61K31/7016 , A61K31/7004 , A61K31/733 , A61P1/00 , A61K35/00
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said gycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.
-
公开(公告)号:US20190091249A1
公开(公告)日:2019-03-28
申请号:US16140091
申请日:2018-09-24
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor: Geoffrey A. von Maltzahn , Yvonne J. Yamanaka , Jared Silverman , John Miles Milwid , Jacob Rosenblum Rubens , John M. Geremia
IPC: A61K31/702 , A61K35/741 , A23L33/135 , A61P35/04 , A61P43/00 , A23L33/125 , A61P1/00 , A61K31/716 , A61K31/733 , A61P35/00 , A61K45/06 , A61P3/02
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions, dietary supplements and medical foods thereof are provided, and methods of using said gycan therapeutics, e.g. in cancer therapy.
-
公开(公告)号:US20180296582A1
公开(公告)日:2018-10-18
申请号:US15568251
申请日:2016-04-23
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor: Geoffrey A. von Maltzahn , John M. Geremia
IPC: A61K31/7004 , A61K9/00 , A61K35/741 , C12Q1/10 , A61K45/06 , A61K31/7016 , A61K31/047 , A61K31/19 , A61K31/198 , A61K31/197
Abstract: Compositions comprising microbiome regulators are provided, as well as methods of using the same for the modulation of the human microbiota and to treat or prevent related diseases, disorders, or conditions.
-
公开(公告)号:US20180147221A1
公开(公告)日:2018-05-31
申请号:US15568243
申请日:2016-04-23
Applicant: KALEIDO BIOSCIENCES, INC.
Inventor: Geoffrey A. von Maltzahn , Yvonne J. Yamanaka , Jared Silverman , Jack Milwid , Jacob R. Rubens , John M. Geremia
IPC: A61K31/702 , A61P43/00 , A61K35/741 , A61P35/00 , A61P1/00 , A61P3/02 , A61K45/06 , A61P35/04 , A23L33/125 , A23L33/135
CPC classification number: A61K31/702 , A23L33/125 , A23L33/135 , A23V2002/00 , A61K31/716 , A61K31/733 , A61K35/741 , A61K45/06 , A61P1/00 , A61P3/02 , A61P35/00 , A61P35/04 , A61P43/00
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions, dietary supplements and medical foods thereof are provided, and methods of using said gycan therapeutics, e.g. in cancer therapy.
-
公开(公告)号:US20210401861A1
公开(公告)日:2021-12-30
申请号:US17363597
申请日:2021-06-30
Applicant: Kaleido Biosciences, Inc.
Inventor: Geoffrey A. von Maltzahn , Yvonne J. Yamanaka , Jared Silverman , John Miles Milwid , Jacob Rosenblum Rubens , John M. Geremia
IPC: A61K31/702 , A61K45/06 , A61K31/716 , A61K31/733 , A23L33/125 , A23L33/135 , A61P3/02 , A61P43/00 , A61P1/00 , A61P35/04 , A61P35/00 , A61K35/741
Abstract: Preparations of glycan therapeutics, pharmaceutical compositions, dietary supplements and medical foods thereof are provided, and methods of using said glycan therapeutics, e.g. in cancer therapy.
-
公开(公告)号:US20210395284A1
公开(公告)日:2021-12-23
申请号:US17292119
申请日:2019-11-08
Applicant: DSM IP Assets B.V. , Midori USA, Inc. , KALEIDO BIOSCIENCES, INC.
Inventor: Manuela BAUR , Estel CANET-MARTINEZ , Ruediger HAINZ , Ulrich HOELLER , Lisa Ann LAPRADE , John Michael GEREMIA , Ghislain SCHYNS
Abstract: The present disclosure relates oligosaccharide preparations suitable for use in nutritional compositions such as animal feed and methods of manufacturing the described oligosaccharide preparations. The present disclosure further relates to nutritional compositions that comprise the oligosaccharide preparations. The disclosed oligosaccharide preparations can be advantageous as an animal feed due to, at least in part, their prebiotic utility and the presence of anhydro-subunit containing oligosaccharides, which can be used to detect and/or determine the presence and content of the disclosed oligosaccharide preparations in the nutritional composition.
-
-
-
-
-
-
-
-
-